Description
The Advanced Research Projects Agency for Health (ARPA-H) is hosting a Proposers' Day for the Agentic AI-EnableD CardioVascular CAre TransfOrmation (ADVOCATE) program. The program aims to revolutionize the management of patients with cardiovascular disease (CVD) by enabling the development of a clinically validated, regulatory-compliant, patient-facing, multimodal agentic system to support and deliver clinical care. The program consists of three technical areas: TA1 - CVD Agent, TA2 - Supervisory Agent, and TA3 - Scalable Implementation. The Proposers' Day will provide an opportunity for potential proposers to learn more about the program and identify potential team members.
Key points to consider:
• The ADVOCATE program is a two-phase, 39-month program.
• The program aims to develop a clinically validated, regulatory-compliant, patient-facing, multimodal agentic system.
• The program consists of three technical areas: TA1 - CVD Agent, TA2 - Supervisory Agent, and TA3 - Scalable Implementation.
• The Proposers' Day will provide an opportunity for potential proposers to learn more about the program and identify potential team members.
• The program will support the development of independent agentic solutions that can continuously monitor and improve the clinical agentic AI deployed in clinical practice.
Attached files
Contact
Dr. Haider Warraich(Program Manager)